Sinotherapeutics Inc. (688247.SS) — Stock Score Summary

Sinotherapeutics Inc. (688247.SS) has a MoatMap StockRank of 35/100 based on Quality (68/100), Value (25/100), and Momentum (30/100) factor scores. The current signal is SELL. Sinotherapeutics is a specialty pharma company focused on drug delivery technologies. It does not possess the large-scale manufacturing moats or global pricing power characteristic of high-conviction CDMOs, making it a poor fit for our current macro themes.

Sinotherapeutics is a specialty pharmaceutical company focused on the development, manufacturing, and commercialization of complex generic and innovative drug formulations. The company's competitive moat lies in its advanced drug delivery technologies, particularly in sustained-release and difficult-to-formulate oral solids. It is a prominent niche player targeting high-barrier generic markets in both China and the United States.

Key Financial Metrics

Price$1.15
Market Cap$571M
P/E (TTM)80.80
Price/Book2.56
Return on Equity3.3%
Return on Invested Capital3.9%
Debt/Equity0.00
Gross Margin39.2%
Operating Margin15.1%
Revenue Growth-13.2%
Dividend Yield0.8%
Free Cash Flow$2M

Sinotherapeutics Inc. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Sinotherapeutics Inc.’s (688247.SS) StockRank?
MoatMap’s StockRank for Sinotherapeutics Inc. (688247.SS) is 35/100, with a Sell signal. It is a composite of Quality (68), Value (25), and Momentum (30) factor ranks across MoatMap’s 19,000+ stock universe.
Does Sinotherapeutics Inc. have an economic moat?
Sinotherapeutics Inc. (688247.SS) has a Quality factor score of 68/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Sinotherapeutics Inc. a buy, hold, or sell?
MoatMap’s current signal for Sinotherapeutics Inc. (688247.SS) is Sell, based on a StockRank of 35/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Sinotherapeutics Inc. in?
Sinotherapeutics Inc. (688247.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).
Browse all ranked stocks688247.SS deep dive reportAI ChampionsHow we score stocksSense-check another stock